WALTHAM, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (NASDAQ:CERU), a clinical-stage company developing nanoparticle-drug conjugates (NDCs), today announced that Cerulean management will present at the following conferences:
• Christopher D. T. Guiffre, President & Chief Executive Officer
28th Annual ROTH Conference in Dana Point, CA
